Zobrazeno 1 - 10
of 96
pro vyhledávání: '"S, Devadatta"'
Autor:
S. Radhakrishna, C. V. Ramakrishnan, P. R. Somasundaram, S.P. Usha, N.K. Menon, S. Devadatta, O. Nazareth, S. Velu
Publikováno v:
Tubercle. 51:263-269
ATI earlier report from this Centre (Tuber-culosis Chemotherapy Centre, Madras, 1964) showed that a fully supervised twice-weekly regimen of streptomycin plus high-dosage isoniazid was highly effective in the treatment of patients with newly-diagnose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b216c31b3e8d51a7989cbfe0fa4bcf7
https://doi.org/10.1016/0041-3879(70)90018-8
https://doi.org/10.1016/0041-3879(70)90018-8
Autor:
C. V. Ramakrishnan, S. Velu, H. Stott, K. Mohan, J. J. Y. Dawson, K.G. Kulkarni, S. Devadatta, Wallace Fox
Publikováno v:
Tubercle. 45:144-159
Summary A controlled comparison has been made of streptomycin plus pyrazinamide (46 patients) and streptomycin plus PAS (36 patients) in the retreatment of patients with pulmonary tuberculosis. The patients had either failed to attain bacteriological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a7c54761539b6f0d2c4afd7c871285
https://doi.org/10.1016/s0041-3879(64)80072-6
https://doi.org/10.1016/s0041-3879(64)80072-6
Autor:
A. L. Bhatia, T. V. Subbaiah, Denis A. Mitchison, S. Devadatta, J. B. Selkon, S. Radhakrishna
Publikováno v:
Tubercle. 42:317-321
Summary Isoniazid- and streptomycin-sensitive cultures of tubercle bacilli, isolated pretreatment from 12 South Indian patients when they first attended the Centre, and at 7 and 42 days thereafter, were tested for their virulence in the guinea-pig. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ab086dca9dcc12cfcd8c755992121c8
https://doi.org/10.1016/s0041-3879(61)80115-3
https://doi.org/10.1016/s0041-3879(61)80115-3
Autor:
P. George Jacob, C. Narayanan Nair, C. V. Ramakrishnan, J.H. Angel, S. Devadatta, R. H. Andrews, S. Velu, Wallace Fox
Publikováno v:
Tubercle. 42:136-147
Summary Fifty-seven patients with chronic pulmonary tuberculosis and organisms sensitive to streptomycin were treated with daily streptomycin plus pyrazinamide, the majority attending a clinic daily for the therapy; all had previously been treated ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945fa914602d790ff67ddc1af914522d
https://doi.org/10.1016/s0041-3879(61)80089-5
https://doi.org/10.1016/s0041-3879(61)80089-5
Autor:
N.K. Menon, S. R. Kamat, S. Radhakrishna, C. Evans, S. Velu, Srikanth Tripathy, S. Devadatta, S. Rajagopalan, H. Stott, C. V. Ramakrishnan
Publikováno v:
Tubercle. 48:114-127
Summary Fifty patients with chronic pulmonary tuberculosis and cultures resistant to isoniazid were treated with a daily regimen of ethionamide (500 mg.) plus cycloserine in an intended dose of 500 mg., but possibly less because of deterioration. Mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307196929552b74475a1a27ae5456217
https://doi.org/10.1016/s0041-3879(67)80006-0
https://doi.org/10.1016/s0041-3879(67)80006-0
Autor:
C. Evans, B. Janardhanam, S. Velu, H. Stott, O. Nazareth, S. Devadatta, Srikanth Tripathy, C. V. Ramakrishnan, S. Radhakrishna, N.K. Menon, Wallace Fox
Publikováno v:
Tubercle. 47:178-189
Summary In the main analysis of a year's study of twice-weekly high dosage isoniazid plus streptomycin (SHTW) in comparison with a standard daily regimen of isoniazid plus PAS (PH) under domiciliary conditions, 66 SHTW and 53 PH patients had attained
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45246bb5313015baa4b25238c323fe7
https://doi.org/10.1016/s0041-3879(66)80034-x
https://doi.org/10.1016/s0041-3879(66)80034-x
Autor:
S. Sambamoorthy, C. Evans, Wallace Fox, H. Stott, S. Radhakrishna, N.K. Menon, Srikanth Tripathy, O. Nazareth, S. Velu, S. Devadatta, C. V. Ramakrishnan
Publikováno v:
Tubercle. 50:115-124
This report describes the progress over a four-year period of follow-up of 119 patients who had bacteriologically quiescent pulmonary tuberculosis at the end of a year of chemotherapy with either a fully supervised twice-weekly regimen of isoniazid p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fedb9275d48fd1ec8eee2d11346aea2
https://doi.org/10.1016/0041-3879(69)90018-x
https://doi.org/10.1016/0041-3879(69)90018-x
Autor:
S. Radhakrishna, J. B. Selkon, J.H. Angel, A. L. Bhatia, H. Stott, Wallace Fox, C. V. Ramakrishnan, S. Velu, B. Janardhanam, S. Devadatta
Publikováno v:
Tubercle. 44:215-224
Summary Twenty-seven patients with chronic pulmonary tuberculosis who had failed to respond to two previous chemotherapeutic regimens were allocated to treatment with cycloserine plus ethionamide (14 patients), or with cycloserine plus thiacetazone (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1f8a24d6bbf445f04178123a67f597
https://doi.org/10.1016/s0041-3879(63)80115-4
https://doi.org/10.1016/s0041-3879(63)80115-4
Studies of immediate adverse reactions to different doses of a slow-release preparation of isoniazid
Autor:
K.V. Krishnaswami, S. Radhakrishna, Wallace Fox, S. Devadatta, R Parthasarathy, Srikanth Tripathy, P. R. Somasundaram
Publikováno v:
Tubercle. 57(2)
'Double-blind' studies were carried out to assess the incidence of immediate adverse reactions to different doses of a slow-release preparation of isoniazid (matrix isoniazid). Individual doses of 30 mg/kg matrix isoniazid were well-tolerated but hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183a4d7729d20d865717bed7aa37220b
https://pubmed.ncbi.nlm.nih.gov/785735
https://pubmed.ncbi.nlm.nih.gov/785735
Publikováno v:
Lancet (London, England). 2(7095)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f946b20a660311353245e384212d129
https://pubmed.ncbi.nlm.nih.gov/13796036
https://pubmed.ncbi.nlm.nih.gov/13796036